<?xml version='1.0' encoding='utf-8'?>
<document id="11856081"><sentence text="Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease."><entity charOffset="20-32" id="DDI-PubMed.11856081.s1.e0" text="azathioprine" /><entity charOffset="37-53" id="DDI-PubMed.11856081.s1.e1" text="aminosalicylates" /><pair ddi="false" e1="DDI-PubMed.11856081.s1.e0" e2="DDI-PubMed.11856081.s1.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s1.e0" e2="DDI-PubMed.11856081.s1.e1" /></sentence><sentence text="The inhibition of thiopurine methyltransferase activity, one of the enzymes responsible for azathioprine metabolism, by aminosalicylates has been described in an in vitro study"><entity charOffset="18-28" id="DDI-PubMed.11856081.s2.e0" text="thiopurine" /><entity charOffset="92-104" id="DDI-PubMed.11856081.s2.e1" text="azathioprine" /><entity charOffset="120-136" id="DDI-PubMed.11856081.s2.e2" text="aminosalicylates" /><pair ddi="false" e1="DDI-PubMed.11856081.s2.e0" e2="DDI-PubMed.11856081.s2.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s2.e0" e2="DDI-PubMed.11856081.s2.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s2.e0" e2="DDI-PubMed.11856081.s2.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s2.e1" e2="DDI-PubMed.11856081.s2.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s2.e1" e2="DDI-PubMed.11856081.s2.e2" /></sentence><sentence text=" This could result in a higher risk of bone marrow depression when using the two drugs together" /><sentence text="" /><sentence text="To investigate the in vivo interaction between azathioprine and aminosalicylates in quiescent Crohn's disease by measuring 6-thioguanine nucleotide levels, thiopurine methyltransferase activity and the plasma levels of the acetylated metabolite of 5-aminosalicylic acid"><entity charOffset="47-59" id="DDI-PubMed.11856081.s5.e0" text="azathioprine" /><entity charOffset="64-80" id="DDI-PubMed.11856081.s5.e1" text="aminosalicylates" /><entity charOffset="123-147" id="DDI-PubMed.11856081.s5.e2" text="6-thioguanine nucleotide" /><entity charOffset="156-166" id="DDI-PubMed.11856081.s5.e3" text="thiopurine" /><entity charOffset="248-269" id="DDI-PubMed.11856081.s5.e4" text="5-aminosalicylic acid" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e0" e2="DDI-PubMed.11856081.s5.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e0" e2="DDI-PubMed.11856081.s5.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e0" e2="DDI-PubMed.11856081.s5.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e0" e2="DDI-PubMed.11856081.s5.e3" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e0" e2="DDI-PubMed.11856081.s5.e4" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e1" e2="DDI-PubMed.11856081.s5.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e1" e2="DDI-PubMed.11856081.s5.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e1" e2="DDI-PubMed.11856081.s5.e3" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e1" e2="DDI-PubMed.11856081.s5.e4" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e2" e2="DDI-PubMed.11856081.s5.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e2" e2="DDI-PubMed.11856081.s5.e3" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e2" e2="DDI-PubMed.11856081.s5.e4" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e3" e2="DDI-PubMed.11856081.s5.e3" /><pair ddi="false" e1="DDI-PubMed.11856081.s5.e3" e2="DDI-PubMed.11856081.s5.e4" /></sentence><sentence text="" /><sentence text="Sixteen patients taking a stable dose of azathioprine, plus sulfasalazine or mesalazine, were enrolled and completed the study"><entity charOffset="41-53" id="DDI-PubMed.11856081.s7.e0" text="azathioprine" /><entity charOffset="60-73" id="DDI-PubMed.11856081.s7.e1" text="sulfasalazine" /><entity charOffset="77-87" id="DDI-PubMed.11856081.s7.e2" text="mesalazine" /><pair ddi="false" e1="DDI-PubMed.11856081.s7.e0" e2="DDI-PubMed.11856081.s7.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s7.e0" e2="DDI-PubMed.11856081.s7.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s7.e0" e2="DDI-PubMed.11856081.s7.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s7.e1" e2="DDI-PubMed.11856081.s7.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s7.e1" e2="DDI-PubMed.11856081.s7.e2" /></sentence><sentence text=" They were not taking any drugs interfering with azathioprine metabolism"><entity charOffset="49-61" id="DDI-PubMed.11856081.s8.e0" text="azathioprine" /></sentence><sentence text=" Four visits every 4 weeks were held over a 3-month period" /><sentence text=" Aminosalicylate administration was withdrawn after the second visit"><entity charOffset="1-16" id="DDI-PubMed.11856081.s10.e0" text="Aminosalicylate" /></sentence><sentence text=" At each visit, the blood cell count, inflammatory parameters, levels of 6-thioguanine nucleotide and the acetylated metabolite of 5-aminosalicylic acid and thiopurine methyltransferase activity were determined"><entity charOffset="73-97" id="DDI-PubMed.11856081.s11.e0" text="6-thioguanine nucleotide" /><entity charOffset="131-152" id="DDI-PubMed.11856081.s11.e1" text="5-aminosalicylic acid" /><entity charOffset="157-167" id="DDI-PubMed.11856081.s11.e2" text="thiopurine" /><pair ddi="false" e1="DDI-PubMed.11856081.s11.e0" e2="DDI-PubMed.11856081.s11.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s11.e0" e2="DDI-PubMed.11856081.s11.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s11.e0" e2="DDI-PubMed.11856081.s11.e2" /><pair ddi="false" e1="DDI-PubMed.11856081.s11.e1" e2="DDI-PubMed.11856081.s11.e1" /><pair ddi="false" e1="DDI-PubMed.11856081.s11.e1" e2="DDI-PubMed.11856081.s11.e2" /></sentence><sentence text="" /><sentence text="After aminosalicylate withdrawal, mean 6-thioguanine nucleotide levels decreased significantly from 148 pmol (57-357 pmol) to 132 pmol (56-247 pmol) per 8 x 10(8) red blood cells (P=0"><entity charOffset="6-21" id="DDI-PubMed.11856081.s13.e0" text="aminosalicylate" /></sentence><sentence text="027), without significant changes in thiopurine methyltransferase activity or biological parameters"><entity charOffset="37-47" id="DDI-PubMed.11856081.s14.e0" text="thiopurine" /></sentence><sentence text="" /><sentence text="This in vivo study favours the existence of an interaction between azathioprine and aminosalicylates through a mechanism which remains unclear"><entity charOffset="67-79" id="DDI-PubMed.11856081.s16.e0" text="azathioprine" /><entity charOffset="84-100" id="DDI-PubMed.11856081.s16.e1" text="aminosalicylates" /><pair ddi="false" e1="DDI-PubMed.11856081.s16.e0" e2="DDI-PubMed.11856081.s16.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s16.e0" e2="DDI-PubMed.11856081.s16.e1" /></sentence><sentence text=" This drug-drug interaction should be taken into account when using azathioprine and aminosalicylates simultaneously"><entity charOffset="68-80" id="DDI-PubMed.11856081.s17.e0" text="azathioprine" /><entity charOffset="85-101" id="DDI-PubMed.11856081.s17.e1" text="aminosalicylates" /><pair ddi="false" e1="DDI-PubMed.11856081.s17.e0" e2="DDI-PubMed.11856081.s17.e0" /><pair ddi="false" e1="DDI-PubMed.11856081.s17.e0" e2="DDI-PubMed.11856081.s17.e1" /></sentence><sentence text="" /></document>